ACUT
Price
$1.98
Change
+$0.08 (+4.21%)
Updated
Aug 28 closing price
Capitalization
31.82M
MOLN
Price
$3.60
Change
-$0.15 (-4.00%)
Updated
Aug 28 closing price
Capitalization
137.95M
62 days until earnings call
Interact to see
Advertisement

ACUT vs MOLN

Header iconACUT vs MOLN Comparison
Open Charts ACUT vs MOLNBanner chart's image
Accustem Sciences
Price$1.98
Change+$0.08 (+4.21%)
Volume$3.99K
Capitalization31.82M
Molecular Partners AG
Price$3.60
Change-$0.15 (-4.00%)
Volume$1.64K
Capitalization137.95M
ACUT vs MOLN Comparison Chart in %
Loading...
ACUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACUT vs. MOLN commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACUT is a Buy and MOLN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (ACUT: $1.98 vs. MOLN: $3.60)
Brand notoriety: ACUT and MOLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACUT: 58% vs. MOLN: 56%
Market capitalization -- ACUT: $31.82M vs. MOLN: $137.95M
ACUT [@Biotechnology] is valued at $31.82M. MOLN’s [@Biotechnology] market capitalization is $137.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACUT’s FA Score shows that 1 FA rating(s) are green whileMOLN’s FA Score has 0 green FA rating(s).

  • ACUT’s FA Score: 1 green, 4 red.
  • MOLN’s FA Score: 0 green, 5 red.
According to our system of comparison, ACUT is a better buy in the long-term than MOLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACUT’s TA Score shows that 3 TA indicator(s) are bullish while MOLN’s TA Score has 5 bullish TA indicator(s).

  • ACUT’s TA Score: 3 bullish, 5 bearish.
  • MOLN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, MOLN is a better buy in the short-term than ACUT.

Price Growth

ACUT (@Biotechnology) experienced а +5.04% price change this week, while MOLN (@Biotechnology) price change was +1.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.15%. For the same industry, the average monthly price growth was +15.07%, and the average quarterly price growth was +29.12%.

Reported Earning Dates

MOLN is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (-1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MOLN($138M) has a higher market cap than ACUT($31.8M). ACUT YTD gains are higher at: 341.964 vs. MOLN (-24.172). ACUT has higher annual earnings (EBITDA): -1.54M vs. MOLN (-57.15M). MOLN has more cash in the bank: 131M vs. ACUT (31.3K). ACUT has less debt than MOLN: ACUT (66.4K) vs MOLN (2.14M). MOLN has higher revenues than ACUT: MOLN (2.23M) vs ACUT (0).
ACUTMOLNACUT / MOLN
Capitalization31.8M138M23%
EBITDA-1.54M-57.15M3%
Gain YTD341.964-24.172-1,415%
P/E RatioN/AN/A-
Revenue02.23M-
Total Cash31.3K131M0%
Total Debt66.4K2.14M3%
TECHNICAL ANALYSIS
Technical Analysis
ACUTMOLN
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
72%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
Bullish Trend 5 days ago
69%
Declines
ODDS (%)
Bearish Trend 15 days ago
80%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
ACUT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MOLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSGZF0.13N/A
+3.68%
TriStar Gold, Inc.
SMECF318.3111.16
+3.63%
SMC Corp
CRWKF63.99N/A
N/A
Cranswick PLC
JNNDF0.14N/A
N/A
Japan Display, Inc.
NKLAQ0.03N/A
-3.54%
Nikola Corporation

ACUT and

Correlation & Price change

A.I.dvisor tells us that ACUT and KMSTF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ACUT and KMSTF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACUT
1D Price
Change %
ACUT100%
+4.21%
KMSTF - ACUT
28%
Poorly correlated
N/A
MOLN - ACUT
21%
Poorly correlated
-3.99%
PHGE - ACUT
20%
Poorly correlated
+0.85%
TELIF - ACUT
11%
Poorly correlated
+2.04%
BLTE - ACUT
11%
Poorly correlated
+0.48%
More

MOLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, MOLN has been loosely correlated with SNSE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if MOLN jumps, then SNSE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MOLN
1D Price
Change %
MOLN100%
-3.99%
SNSE - MOLN
39%
Loosely correlated
+4.18%
SLDB - MOLN
36%
Loosely correlated
N/A
RCKT - MOLN
33%
Poorly correlated
+0.90%
ATRA - MOLN
31%
Poorly correlated
+0.08%
RAPT - MOLN
30%
Poorly correlated
-1.63%
More